14/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

14/04/2024

Apr 14, 2024, 10:52 | Positive
Stacy Wentworth: Incredible achievement that inspired me to write about another transplant 'first'
Stacy Wentworth, Consultant at Cancer Culture, shared a post by Massachusetts General Hospital, on LinkedIn:…
Apr 14, 2024, 10:45 | Drugs
Final pre-spectified overall survival analysis of CLEAR, a phase III study - summarized by Yuksel Urun
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 14, 2024, 10:37 | Blog
Elizabeth Prsic: Our work on hospice referrals among patients with cancer was featured on Becker's Hospital Review
Elizabeth Prsic, Director of Inpatient Palliative Care at Smilow Cancer Hospital, shared on X: “Our…
Apr 14, 2024, 10:33 | Opinion
Elad Sharon: Designing clinical trials is all about tradeoffs
Elad Sharon, Clinical and Translational Director of Immunotherapy Toxicity Service at Dana-Farber Cancer Institute, shared…
Apr 14, 2024, 10:26 | Insight
Iván González: A comprehensive review of immune system adverse events due to cancer immunotherapy
Iván González, Medical Oncologist at Comprehensive Oncology Center of the Hospital Ángeles Puebla, shared on…
Apr 14, 2024, 10:22 | Blog
Polina Wright presents her research, elucidating the role of transglutaminase 2 in pancreatic cancer - VCU Massey Comprehensive Cancer Center
VCU Massey Comprehensive Cancer Center shared on their X/Twitter: ''At AACR24, Polina Wright, a student…
Apr 14, 2024, 08:29 | Blog
Isabel Mestres: Health is not just a privilege for a selected few, but a fundamental human right
Isabel Mestres, CEO at City Cancer Challenge Foundation, posted LinkedIn: ''Health is not just a…
Apr 14, 2024, 08:20 | Blog
Meet Esther diagnosed with cancer and admitted to QECH in Malawi - CANCaRe Africa
CANCaRe Africa, shared on X/Twitter: "Please meet Esther who was diagnosed with cancer and admitted to…
Apr 14, 2024, 07:51 | Insight
New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach
Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach  Published in Journal for ImmunoTherapy of Cancer,…
Apr 14, 2024, 07:44 | Blog
Kimryn Rathmell: From ‘Fearless’ breakthroughs to ‘Red’ hot discoveries, the next era of cancer research is here
Kimryn Rathmell, Director of the National Cancer Institute, shared a post on X/Twitter: "From ‘Fearless’ breakthroughs…
All: 67 Posts: 31 - 40